| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Centre de Recherche en Cancérologie de l’Université Laval. Pavillon Hôtel-Dieu de Québec, Quebec, Quebec G1R 2J6, Canada [M. L.]; Department of Pathology, The University of California, Davis, Center for Comparative Medicine, University of California, Davis, CA 95616 [R. D. C.]; and Department of Genetics, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115 [P. L.]
Werner syndrome is an autosomal recessive disorder characterized by genomic instability and by the premature onset of a number of age-related diseases, including malignancy. To assess a potential collaboration between p21 or p53 cell cycle regulators and Wrn proteins, Wrn mutant mice were created and mated with p21 or p53 null mice to generate double mutants. The p21 null/Wrn mutant mice did not show an acceleration of tumorigenesis during the first year of life, suggesting that the p53-dependent G1-S cell cycle checkpoint (which operates via p21) is not involved in Wrn-abetted tumor suppression. In contrast, the p53 null/Wrn mutant mice were particularly remarkable with respect to the rapidity with which they developed tumors. These mice were also distinguished by the variety of tumors they developed compared to those that developed in p53 null mice. Such data suggest a genetic interaction between p53 and Wrn in which loss of Wrn provokes a more variable p53 response unrelated to its role in the G1-S cell cycle checkpoint.
This article has been cited by other articles:
|
|
 |
|
  T. K.S. Ku, D. C. Nguyen, M. Karaman, P. Gill, J. G. Hacia, and D. L. Crowe Loss of p53 Expression Correlates with Metastatic Phenotype and Transcriptional Profile in a New Mouse Model of Head and Neck Cancer Mol. Cancer Res., April 1, 2007; 5(4): 351 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sharma, D. J. Stumpo, A. S. Balajee, C. B. Bock, P. M. Lansdorp, R. M. Brosh Jr., and P. J. Blackshear RECQL, a Member of the RecQ Family of DNA Helicases, Suppresses Chromosomal Instability Mol. Cell. Biol., March 1, 2007; 27(5): 1784 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Barboza, G. Liu, Z. Ju, A. K. El-Naggar, and G. Lozano p21 delays tumor onset by preservation of chromosomal stability PNAS, December 26, 2006; 103(52): 19842 - 19847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Cardiff Epithelial to Mesenchymal Transition Tumors: Fallacious or Snail's Pace? Clin. Cancer Res., December 15, 2005; 11(24): 8534 - 8537. [Full Text] [PDF]
|
|
|
|
 |
|
 J R Porter and T G Barrett Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and {beta} cell failure J. Med. Genet., December 1, 2005; 42(12): 893 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Shen, H. Heng, Y. Wang, S. Lu, G. Liu, C.-X. Deng, S.C. Brooks, and Y. A. Wang ATM and p21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development Cancer Res., October 1, 2005; 65(19): 8747 - 8753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Opresko, W.-H. Cheng, C. von Kobbe, J. A. Harrigan, and V. A. Bohr Werner syndrome and the function of the Werner protein; what they can teach us about the molecular aging process. Carcinogenesis, May 1, 2003; 24(5): 791 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lebel, J. Lavoie, I. Gaudreault, M. Bronsard, and R. Drouin Genetic Cooperation between the Werner Syndrome Protein and Poly(ADP-Ribose) Polymerase-1 in Preventing Chromatid Breaks, Complex Chromosomal Rearrangements, and Cancer in Mice Am. J. Pathol., May 1, 2003; 162(5): 1559 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Hasty, J. Campisi, J. Hoeijmakers, H. van Steeg, and J. Vijg Aging and Genome Maintenance: Lessons from the Mouse? Science, February 28, 2003; 299(5611): 1355 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fry The Werner Syndrome Helicase-Nuclease--One Protein, Many Mysteries Sci. Aging Knowl. Environ., April 3, 2002; 2002(13): re2 - 2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Werner mouse Wrn-{Delta}hel Sci. Aging Knowl. Environ., April 3, 2002; 2002(13): tg4 - 4. [Full Text]
|
|
|
|
|
|
M. Lebel Increased frequency of DNA deletions in pink-eyed unstable mice carrying a mutation in the Werner syndrome gene homologue Carcinogenesis, January 1, 2002; 23(1): 213 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Martin-Caballero, J. M. Flores, P. Garcia-Palencia, and M. Serrano Tumor Susceptibility of p21Waf1/Cip1-deficient Mice Cancer Res., August 1, 2001; 61(16): 6234 - 6238. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
